Trials / Sponsors / Shirish M Gadgeel
Shirish M Gadgeel
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Pat Lung Cancer, Non-small Cell Lung Cancer, PD-L1 Gene Mutation | Phase 2 | 2021-04-06 |